Announcements Trials
Browse Landscape

Phase

Phase 4 5Phase 3 5Phase NA 4Phase 2 4Phase EARLY_PHASE1 2Phase 1/2 1Phase 1 1

Status

Withdrawn 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Dermatologic 4

Conditions

Colorectal Neoplasms 220Rectal Neoplasms 137Stomach Neoplasms 95Colonic Neoplasms 87Pancreatic Neoplasms 82Esophageal Neoplasms 71Neoplasm Metastasis 58Squamous Cell Carcinoma of Head and Neck 43Head and Neck Neoplasms 42Adenocarcinoma Of Esophagus 37Neoplasms 36Breast Neoplasms 35Esophageal Squamous Cell Carcinoma 27Carcinoma, Hepatocellular 22Cholangiocarcinoma 21Adenocarcinoma 17Nasopharyngeal Carcinoma 16Bile Duct Neoplasms 14Gallbladder Neoplasms 13Carcinoma, Squamous Cell 13Biliary Tract Neoplasms 13Anus Neoplasms 13Urinary Bladder Neoplasms 11Liver Neoplasms 10Carcinoma 9Nasopharyngeal Neoplasms 8Colorectal Cancer Metastatic 8Peritoneal Neoplasms 7Recurrence 6Ovarian Neoplasms 6

Interventions

Aminolevulinic Acid 113-ingenyl angelate 9Photochemotherapy 5Imiquimod 5Fluorouracil 4Petrolatum 3Solutions 2SR-T100 2Gels 2Cryotherapy 2potassium dobesilate 1perillyl alcohol 1endonuclease V, phage T4 1dehydroftorafur 1calcipotriene 1afamelanotide 1Triamcinolone 1Therapies, Investigational 1Papillomavirus Vaccines 1Ointments 1Melatonin 1Lasers 1LEO 43204 1Isotretinoin 1Imipramine 1Excipients 1Eflornithine 1Deoxyribonuclease (Pyrimidine Dimer) 1Cholecalciferol 1Chemexfoliation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Keratosis, Actinic × Fluorouracil × Clear all
NCT05699603 2025-09-24

Testing the Efficacy of Topical Calcipotriene Plus 5-Fluorouracil Combination to Activate the Immune System Against Precancerous Skin Lesions in Organ Transplant Recipients

University of Arizona

Phase 2 Active not recruiting
56 enrolled
Dermatologic

Keratosis, Actinic

NCT04329221 2025-05-07

Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients

Massachusetts General Hospital

Phase 2 Withdrawn
Dermatologic

Carcinoma, Squamous Cell, Skin Neoplasms, Keratosis, Actinic

NCT04642287 2025-05-07

Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients

Massachusetts General Hospital

Phase 2 Withdrawn
Dermatologic

Carcinoma, Squamous Cell, Skin Neoplasms, Keratosis, Actinic

NCT05740969 2023-02-23

PACKS

Zealand University Hospital

Phase 2 Unknown
48 enrolled
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡